Noncanonical contribution of microglial transcription factor NR4A1 to post-stroke recovery through TNF mRNA destabilization

PLoS Biol. 2023 Jul 24;21(7):e3002199. doi: 10.1371/journal.pbio.3002199. eCollection 2023 Jul.

Abstract

Microglia-mediated neuroinflammation is involved in various neurological diseases, including ischemic stroke, but the endogenous mechanisms preventing unstrained inflammation is still unclear. The anti-inflammatory role of transcription factor nuclear receptor subfamily 4 group A member 1 (NR4A1) in macrophages and microglia has previously been identified. However, the endogenous mechanisms that how NR4A1 restricts unstrained inflammation remain elusive. Here, we observed that NR4A1 is up-regulated in the cytoplasm of activated microglia and localizes to processing bodies (P-bodies). In addition, we found that cytoplasmic NR4A1 functions as an RNA-binding protein (RBP) that directly binds and destabilizes Tnf mRNA in an N6-methyladenosine (m6A)-dependent manner. Remarkably, conditional microglial deletion of Nr4a1 elevates Tnf expression and worsens outcomes in a mouse model of ischemic stroke, in which case NR4A1 expression is significantly induced in the cytoplasm of microglia. Thus, our study illustrates a novel mechanism that NR4A1 posttranscriptionally regulates Tnf expression in microglia and determines stroke outcomes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Inflammation
  • Ischemic Stroke*
  • Mice
  • Microglia
  • RNA, Messenger
  • Stroke*
  • Transcription Factors

Substances

  • Transcription Factors
  • RNA, Messenger

Grants and funding

This work was supported by the National Natural Science Foundation of China (81630028, 81920108017, to Y.X.) and the Key Research and Development Program of Jiangsu Province of China (BE2020620, to Y.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.